Response to "Health-Related Quality of Life After Neonatal Treatment of Symptomatic Tetralogy of Fallot: Insights from the Congenital Cardiac Research Collaborative".

This piece of writing commends the article "Health Related Quality of Life After Neonatal Treatment of Symptomatic Tetralogy of Fallot" for its contributions to pediatric cardiology while noting key limitations. The limited sample size may limit generalizability, and further investigation of comorbidities is required to understand their influence on health-related quality of life (HRQOL). The lack of a control group limits interpretation, and longer follow-up periods are required to capture the changing obstacles experienced by children after therapy. Addressing these challenges will provide better insights into HRQOL for children with symptomatic Tetralogy of Fallot and improve treatment procedures.